The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage

References

• Fenton SS, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334–342. doi:10.1016/S0272-6386(97)90276-69292560
   PubMed Web of Science ®Google Scholar
• Huang CC, Cheng KF, Wu HD. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int. 2008;28(Suppl 3):S15–S20.18552246
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011;171:110–118. doi:10.1001/archinternmed.2010.35220876398
   PubMed Web of Science ®Google Scholar
• Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl. 2006;S3–S11. doi:10.1038/sj.ki.5001910
   PubMedGoogle Scholar
• Han SH, Lee SC, Ahn SV, et al. Improving outcome of CAPD: twenty-five years’ experience in a single Korean center. Perit Dial Int. 2007;27:432–440.17602152
   PubMed Web of Science ®Google Scholar
• Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int Suppl. 1997;62:S105–S107.9350695
   PubMedGoogle Scholar
• Lee YC, Hung SY, Wang HH, et al. Different risk of common gastrointestinal disease between groups undergoing hemodialysis or peritoneal dialysis or with non-end stage renal disease: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94:e1482. doi:10.1097/MD.000000000000148226356710
   PubMed Web of Science ®Google Scholar
• Nakamoto H, Kawaguchi Y, Suzuki H. Is technique survival on peritoneal dialysis better in Japan? Perit Dial Int. 2006;26:136–143.16623414
   PubMed Web of Science ®Google Scholar
• Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O. Current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Perit Dial Int. 1999;19(Suppl 2):S445–S449.10406562
   PubMedGoogle Scholar
• Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997;17:360–364.9284463
   PubMed Web of Science ®Google Scholar
• Andreoli SP, Langefeld CD, Stadler S, Smith P, Sears A, West K. Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis. Pediatr Nephrol. 1993;7:543–547. doi:10.1007/BF008525418251318
   PubMedGoogle Scholar
• Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998;54:2207–2217. doi:10.1046/j.1523-1755.1998.00180.x9853287
   PubMed Web of Science ®Google Scholar
• Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12:1046–1051.11316864
   PubMed Web of Science ®Google Scholar
• Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int. 1999;55:341–356. doi:10.1046/j.1523-1755.1999.00264.x9893150
   PubMed Web of Science ®Google Scholar
• Lee YC, Tsai YS, Hung SY, et al. Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells. BMC Nephrol. 2014;15:35. doi:10.1186/1471-2369-15-3524555732
   PubMedGoogle Scholar
• Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348:403–413. doi:10.1056/NEJMoa02080912556543
   PubMed Web of Science ®Google Scholar
• Yang AH, Chen JY, Lin YP, Huang TP, Wu CW. Peritoneal dialysis solution induces apoptosis of mesothelial cells. Kidney Int. 1997;51:1280–1288. doi:10.1038/ki.1997.1759083298
   PubMedGoogle Scholar
• Zheng Z, Ye R, Yu X, Bergstrom J, Lindholm B. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model. Adv Perit Dial. 2001;17:53–57.11510297
   PubMedGoogle Scholar
• Aguilera A, Yanez-Mo M, Selgas R, Sanchez-Madrid F, Lopez-Cabrera M. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs. 2005;6:262–268.
   PubMedGoogle Scholar
• Selgas R, Bajo MA, Aguilera A, et al. Epithelial-mesenchymal transition in fibrosing processes. Mesothelial cells obtained ex vivo from patients treated with peritoneal dialysis as transdifferentiation model. Nefrologia. 2004;24:34–39.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mateo GT, Fernandez-Millara V, Bellon T, et al. Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production. PLoS One. 2014;9:e108477. doi:10.1371/journal.pone.010847725279459
   PubMedGoogle Scholar
• Hirose M, Nishino T, Obata Y, et al. 22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model. Perit Dial Int. 2013;33:132–142. doi:10.3747/pdi.2011.0023423032084
   PubMedGoogle Scholar
• Lee CJ, Subeq YM, Lee RP, Liou HH, Hsu BG. Calcitriol decreases TGF-beta1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats. Cytokine. 2014;65:105–118. doi:10.1016/j.cyto.2013.10.00324210651
   PubMed Web of Science ®Google Scholar
• Lee YC, Hung SY, Liou HH, et al. Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells. Biomed Res Int. 2015;2015:595030. doi:10.1155/2015/59503026495304
   PubMedGoogle Scholar
• Nevozhay D, Kanska U, Budzynska R, Boratynski J. [Current status of research on conjugates and related drug delivery systems in the treatment of cancer and other diseases]. Postepy Hig Med Dosw. 2007;61:350–360.
   Google Scholar
• Palvai S, Nagraj J, Mapara N, Chowdhury R, Basu S. Dual drug loaded vitamin D3 nanoparticle to target drug resistance in cancer. RSC Adv. 2014;4:57271–57281. doi:10.1039/C4RA06475E
   Web of Science ®Google Scholar
• Patil S, Gawali S, Patil S, Basu S. Synthesis, characterization and in vitro evaluation of novel vitamin D3 nanoparticles as a versatile platform for drug delivery in cancer therapy. J Mater Chem B. 2013;1:5742. doi:10.1039/c3tb21176b
   PubMed Web of Science ®Google Scholar
• Rongjie FU, Jianzhong LI, Wang Y. Fat-soluble vitamins analysis on an agilent ZORBAX eclipse PAH polymeric C18 bonded column. Agilent Technol. 2010;5990–5342EN.
   Google Scholar
• Diaz C, Selgas R, Castro MA, Bajo MA, Fernandez de Castro M, Molina S, Jimenez C, Ortiz A, Vara F. Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parameters. Adv Perit Dial. 1998;14:19–24.10649684
   PubMedGoogle Scholar
• Loureiro J, Schilte M, Aguilera A, et al. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant. 2010;25:1098–1108. doi:10.1093/ndt/gfp61820067910
   PubMed Web of Science ®Google Scholar
• Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76–83. doi:10.1038/3500002510655586
   PubMed Web of Science ®Google Scholar
• Li C, Ren Y, Jia X, et al. Twist overexpression promoted epithelial-to-mesenchymal transition of human peritoneal mesothelial cells under high glucose. Nephrol Dial Transplant. 2012;27:4119–4124. doi:10.1093/ndt/gfs04922498918
   PubMed Web of Science ®Google Scholar
• Wang J, Slominski A, Tuckey RC, et al. 20-hydroxyvitamin D(3) inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer Res. 2012;32:739–746.22399586
   PubMed Web of Science ®Google Scholar
• Zhu F, Li T, Qiu F, et al. Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats. Am J Pathol. 2010;176:650–659. doi:10.2353/ajpath.2010.09044720056840
   PubMedGoogle Scholar
• Sengupta P, Basu S, Soni S, et al. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc Natl Acad Sci U S A. 2012;109:11294–11299. doi:10.1073/pnas.120312910922733767
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771–782. doi:10.1038/nrd261418758474
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9:615–627. doi:10.1038/nrd259120616808
   PubMed Web of Science ®Google Scholar
• Yameen B, Choi WI, Vilos C, Swami A, Shi J, Farokhzad OC. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 2014;190:485–499. doi:10.1016/j.jconrel.2014.06.03824984011
   PubMed Web of Science ®Google Scholar
• Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2:214–221. doi:10.1038/nrd103312612647
   PubMed Web of Science ®Google Scholar
• Wang R, Xiao R, Zeng Z, Xu L, Wang J. Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery. Int J Nanomedicine. 2012;7:4185–4198. doi:10.2147/IJN.S3448922904628
   PubMed Web of Science ®Google Scholar
• Ramalho MJ, Loureiro JA, Gomes B, Frasco MF, Coelho MA, Pereira MC. PLGA nanoparticles as a platform for vitamin D-based cancer therapy. Beilstein J Nanotechnol. 2015;6:1306–1318. doi:10.3762/bjnano.6.13526199834
   PubMed Web of Science ®Google Scholar
• Almouazen E, Bourgeois S, Jordheim LP, Fessi H, Briancon S. Nano-encapsulation of vitamin D3 active metabolites for application in chemotherapy: formulation study and in vitro evaluation. Pharm Res. 2013;30:1137–1146. doi:10.1007/s11095-012-0949-423225028
   PubMed Web of Science ®Google Scholar
• Kamaly N, He JC, Ausiello DA, Farokhzad OC. Nanomedicines for renal disease: current status and future applications. Nat Rev Nephrol. 2016;12:738–753. doi:10.1038/nrneph.2016.15627795549
   PubMed Web of Science ®Google Scholar